Synaptiflora
Microbiome intellegence platform to transform product innovation across pharmaceuticals, nutrition,
Company Overview
Snapshot
Founded in September 2024, Synaptiflora operates with 1–10 employees. The company has raised $10K across one funding round, demonstrating early-stage financial traction. Synaptiflora is actively developing an AI-powered microbiome intelligence platform, positioning itself at the forefront of biological data analysis for various industries.
Business overview
Synaptiflora is an AI-powered microbiome intelligence startup that develops a foundational platform to understand and predict how the human microbiome influences drug response, disease biology, and product performance. Its core technology combines strain-level microbiome indexing, a proprietary ex vivo high-throughput screening system, and machine-learning models trained on large human microbiome datasets. The company primarily serves pharmaceutical R&D, aiming to improve clinical trial success, patient stratification, and drug efficacy, and also extends its intelligence layer to nutrition, cosmetics, and agriculture for microbiome-aware product design and innovation. Synaptiflora operates within the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology and Digital Healthcare.
Strategic signal
In September 2025, Synaptiflora was recognized by StartUs Insights as one of the top AI drug discovery companies. This inclusion signals external validation of the company's innovative approach and potential impact within the highly competitive AI-driven pharmaceutical research and development landscape, suggesting a strong forward trajectory in leveraging artificial intelligence for biological insights.
Company Intelligence Q&A
- What is Synaptiflora's primary focus?
- Synaptiflora focuses on building an AI-powered microbiome intelligence platform to understand and predict the influence of the human microbiome on drug response, disease biology, and product performance across various industries.
- When was Synaptiflora founded?
- Synaptiflora was founded in September 2024.
- What is the total funding raised by Synaptiflora?
- Synaptiflora has raised a total of $10K across one funding round. This funding was secured at the Pre-Funding stage.
- Which industries does Synaptiflora's platform serve?
- Synaptiflora's platform initially focuses on pharmaceutical R&D but also extends its intelligence layer to nutrition, cosmetics, and agriculture.
- What recognition did Synaptiflora receive in 2025?
- In September 2025, Synaptiflora was listed by StartUs Insights as one of the top AI drug discovery companies, highlighting its innovative contributions to the field.